{
    "organizations": [],
    "uuid": "abeef05452fa36d79aca3bc04ca8caeb906081ed",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-senzagen-signs-license-agreement-i/brief-senzagen-signs-license-agreement-in-usa-idUSFWN1QP06U",
    "ord_in_thread": 0,
    "title": "BRIEF-Senzagen Signs License Agreement In USA",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 7 (Reuters) - SENZAGEN AB:\n* SENZAGEN SIGNS KEY LICENSE AGREEMENT IN THE US WITH BURLESON RESEARCH TECHNOLOGIES‍\n* BRT WILL MARKET AND PROVIDE GARD IN US AND PERFORM TEST IN ITS LABORATORY IN NORTH CAROLINA​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-03-07T17:04:00.000+02:00",
    "crawled": "2018-03-08T17:35:18.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "senzagen",
        "ab",
        "senzagen",
        "sign",
        "key",
        "license",
        "agreement",
        "u",
        "burleson",
        "research",
        "brt",
        "market",
        "provide",
        "gard",
        "u",
        "perform",
        "test",
        "laboratory",
        "north",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}